Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-19T07:36:21.352Z Has data issue: false hasContentIssue false
  • English
  • Français

Delusional Depressions: Natural History and Response to Treatment

Published online by Cambridge University Press:  29 January 2018

Shepard J. Kantor  and
Alexander H. Glassman
Shepard J. Kantor
Affiliation:
College of Physicians and Surgeons, Columbia University; Attending Psychiatrist, Department of Biological Psychiatry, New York State Psychiatric Institute
Alexander H. Glassman
Affiliation:
College of Physicians and Surgeons, Columbia University; Affective Disease Unit, Department of Biological Psychiatry, New York State Psychiatric Institute; Albert Einstein College of Medicine, New York, USA
Get access Rights & Permissions [Opens in a new window]

Abstract

A review of the abundant literature concerning the distinction between delusional and non-delusional depressions, especially of the work of Aubrey Lewis, reveals that before the introduction of specific therapies most in-patients with major depressive illness eventually recovered; the small percentage who did not almost all came from the delusional group. The dichotomy lost its clinical significance after the introduction of ECT, as both groups were equally responsive. However, accumulating evidence indicates that unipolar delusional depressives are significantly less responsive to tricyclic anti-depressant therapy than non-delusional depressives. The presence or absence of delusional thinking should be considered as a significant criterion in the classification of depressive disorders, and the presence or absence of delusional thinking should influence the choice of treatment for severely depressed patients.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 131 , Issue 4 , October 1977 , pp. 351 - 360
Copyright
Copyright © Royal College of Psychiatrists, 1977 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, E. W. (1936) Prognosis of the depressions of later life. Journal of Mental Science, 82, 559–88.Google Scholar
Angst, J. (1961) A clinical analysis of the effects of Tofranil in depression. Psychopharmacologia, 2, 381–407.Google Scholar
Beckmann, H. & Goodwin, F. (1975) Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Archives of General Psychiatry, 33, 17–21.Google Scholar
Bruce, E. M., Crone, M. B., Fitzpatrigk, G. el al (1960) A comparative trial of EOT and Tofranil. American Journal of Psychiatry, 117, 76.Google Scholar
Chodoff, P., Legault, O. & Freeman, W. (1950) Ambulatory shock therapy. Diseases of the Nervous System, 11, 195–201.Google ScholarPubMed
Feighner, J. P., Robbins, E., Guze, S. B. et al (1972) Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57–63.Google Scholar
Freyhan, F. A. (1960) The modern treatment of depressive disorders. American Journal of Psychiatry, 116, 1057–64.Google Scholar
Friedman, C., De Mowbray, M. S. & Hamilton, V. (1961) Imipramine (Tofranil) in depressive states. Journal of Mental Science, 107, 948–53.CrossRefGoogle ScholarPubMed
Glassman, A. H., Kantor, S. J. & Shostak, M. (1975) Depression, delusions and drug response. American Journal of Psychiatry, 132, 716–19.Google Scholar
Glassman, A. H. & Perel, J. M. (1973) The clinical pharmacology of imipramine. Archives of General Psychiatry, 28, 649–53.Google Scholar
Glassman, A. H., Perel, J. M., Shostak, M., Kantor, S. J. & Fleiss, J. L. (1977) Clinical implications of imipramine plasma levels for depressive illness. Archives of General Psychiatry, 34, 197–204.Google Scholar
Glassman, A. H., Shostak, M., Kantor, S. J. et al (1975) Plasma levels of imipramine and clinical outcome. Psychopharmacology Bulletin, 11, 27–8.Google Scholar
Glassman, A. H., Shostak, M., Kantor, S. J. & Perel, J. M. (1975) Antidepressant plasma levels and the treatment of depression. Read at the Conefrence on Phenomenology and Treatment of Depression, Baylor College of Medicine, Texas Medical Center, Houston, Texas, Dec. 1975. (To be published, Spectrum, 1977.) Google Scholar
Greenblatt, M., Grosser, G. H. & Wechsler, H. (1964) Differential response of hospitalized depressed patients to somatic therapy. American Journal of Psychiatry, 120, 935–43.CrossRefGoogle ScholarPubMed
Guze, S. B., Woodruff, R. A. & Clayton, P. (1975) The significance of psychotic affective disorders. Archives of General Psychiatry, 32, 1147–50.CrossRefGoogle ScholarPubMed
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.CrossRefGoogle ScholarPubMed
Hamilton, M. & White, J. M. (1960) Factors related to the outcome of depression treated with ECT. Journal of Mental Science, 106, 1031–41.CrossRefGoogle Scholar
Hippius, H. & Jantz, H. (1959) Die heutige Behandlung der Depressionen. Der Nervenarzt, 30, 466–73.Google Scholar
Hobson, R. F. (1953) Prognostic factors in electric convulsive therapy. Journal of Neurology, Neurosurgery and Psychiatry, 16, 275–81.Google Scholar
Hoch, A. & MacCurdy, J. T. (1922) The prognosis of involution melancholia. Archives of Neurology and Psychiatry, 7, 1–17.Google Scholar
Hoff, H. (1959) Indications for electroshock, Tofranil and psychotherapy in the treatment of depressions. Canadian Psychiatric Association Journal, 4 (suppl), 55–64.Google Scholar
Hollister, L. & Overall, J. E. (1965) Reflections in the specificity of action of anti-depressants. Psychosomatics, 6, 361–5.Google Scholar
Hollister, L., Overall, J. E., Shelton, J. et al (1967) Drug therapy of depression. Archives of General Psychiatry, 17, 486–93.Google Scholar
Hordern, A., Burt, C. G., Holt, N. F. et al (1965) Depressive States: a Pharmacotherapeutic Study. Springfield: Charles C. Thomas.Google Scholar
Hordern, A., Holt, N. F., Bert, C. G. et al (1963) Amitriptyline in depressive states. British Journal of Psychiatry, 109, 815–25.CrossRefGoogle ScholarPubMed
Huston, P. E. (1948) Involutional psychosis. Archives of Neurology and Psychiatry, 59, 385–94.Google Scholar
Huston, P. E. & Locher, L. M. (1948) Manic depressive psychosis. Archives of Neurology and Psychiatry, 60, 37–48.Google Scholar
Jarvie, H. F. & Glas, M. B. (1950) On atypicality and the depressive state. Journal of Mental Science, 96, 208–25.Google Scholar
Kalinowsky, L. B. (1948) Failures with electric shock therapy. In Failures in Psychiatric Treatment (ed. Hoch, P. H.). New York: Grune & Stratton.Google Scholar
Kalinowsky, L. B. (1959) Organic (non-drug therapy of depression. Canadian Psychiatric Association Journal, 4, S138–47.Google Scholar
Kasanin, J. (1933) The acute schizoaffective psychoses. American Journal of Psychiatry, 13, 97–126.Google Scholar
Klein, D. F. (1974) Endogenomorphic depression. Archives of General Psychiatry, 31, 447–54.CrossRefGoogle ScholarPubMed
Kasanin, J. & Fink, M. (1962) Psychiatric reaction patterns to imipramine. American Journal of Psychiatry, 119, 432–8.Google Scholar
Kragh-Sørenson, P. (1975) The relationship between nortriptyline plasma levels and clinical effects. Proceedings of the Royal Society of Medicine, 68, 99–102.CrossRefGoogle Scholar
Lewis, A. J. (1934) Melancholia: a historical review. Journal of Mental Science, 80, 1–42.Google Scholar
Lewis, A. J. (1934) Melancholia: clinical survey of depressed states. Journal of Mental Science, 80, 277–378.CrossRefGoogle Scholar
Lewis, A. J. (1936) Melancholia: prognostic study and case material. Journal of Mental Science, 82, 488–558.Google Scholar
Lewis, N. D. C. & Hubbard, L. D. (1931) The mechanisms and prognostic aspects of manic-depressive-schizophrenic combinations. Association for Research in Nervous and Mental Disease, 11, 539–610.Google Scholar
Maas, J. W. (1975) Biogenic amines and depression. Archives of General Psychiatry, 32, 1157–61.Google Scholar
Maas, J. W., Fawcett, J. A. & Dekirmenjian, H. (1972) Catecholamine metabolism, depressive illness and drug response. Archives of General Psychiatry, 26, 252–62.CrossRefGoogle ScholarPubMed
Meltzer, H. Y., Cho, H. W., Carroll, B. J. et al (1976) Serum doparnine-β-hydroxylase activity in the affective psychoses and schizophrenia. Archives of General Psychiatry, 33, 585–91.CrossRefGoogle Scholar
Morris, J. B. & Beck, A. T. (1974) The efficacy of antidepressant drugs. Archives of General Psychiatry, 30, 667–74.Google Scholar
Morrison, J., Clancy, J., Crowe, R. et al (1972) The Iowa 500. Archives of General Psychiatry, 27, 457–61.CrossRefGoogle ScholarPubMed
Morrison, J., Winokur, G., Crowe, R. et al (1973) The Iowa 500. Archives of General Psychiatry, 29, 678–82.Google Scholar
Murphy, G. E., Woodruff, R. A. & Herjanic, M. (1974) Primary affective disorder. Archives of General Psychiatry, 31, 181–4.Google Scholar
Murphy, G. E., Woodruff, R. A., Herjanic, M. et al (1974) Validity of the diagnosis of primary affective disorder. Archives of General Psychiatry, 30, 751–6.Google Scholar
Murphy, G. E., Woodruff, R. A., Herjanic, M. et al (1974) Variability of the clinical course of primary affective disorder. Archives of General Psychiatry, 30, 757–61.Google Scholar
Norris, A. S. & Clancy, J. (1961) Hospitalized depressions. Archives of General Psychiatry, 5, 276–9.Google Scholar
Overall, J. E., Hollister, L. E., Johnson, M. et al (1966) Nosology of depression and differential response to drugs. Journal of the American Medical Association, 195, 946–8.Google Scholar
Overall, J. E., Hollister, L. E., Meyer, F. et al (1964) Imipramine and thioridazine in depressed and schizophrenic patients. Journal of the American Medical Association, 189, 605–8.Google Scholar
Paykel, E. S. (1972) Depressive typologies and response to amitriptyline. British Journal of Psychiatry, 120, 147–56.CrossRefGoogle ScholarPubMed
Pickering, G. et al (1965) Clinical trial of the treatment of depressive illness. British Medical Journal, i, 881–6.Google Scholar
Raskin, A. (1973) A guide for drug use in depressive disorders. American Journal of Psychiatry, 131, 181–5.Google Scholar
Raskin, A., Schulterbrandt, J. G., Reatig, N. et al (1970) Differential response to chlorpromazine, imipramine. and placebo. Archives of General Psychiatry, 23, 164–73.Google Scholar
Rees, L., Brown, A. C. & Benaim, S. (1961) A controlled trial of imipramine (Tofranil) in the treatment of severe depressive states. Journal of Mental Science, 107, 552–9.Google ScholarPubMed
Robin, A. A. & Harris, J. A. (1962) A controlled comparison of imipramine and electroplexy. Journal of Mental Science, 108, 217–19.Google Scholar
Robin, A. A. & Langley, G. E. (1964) A controlled trial of imipramine. British Journal of Psychiatry, 110, 419–22.Google Scholar
Robinson, D. S., Nies, A., Ravaris, L. et al (1975) The monoamine oxidase inhibitor, phenalazine in the treatment of depressive-anxiety states. Archives of General Psychiatry, 29, 407–13.Google Scholar
Sandifer, M. G., Wilson, I. C. & Gambill, J. M. (1965) The influence of case selection and dosage in an antidepressant drug trial. British Journal of Psychiatry, 111, 142–8.Google Scholar
Sargant, W. (1960) The physical treatments of depression: their indications and proper use. Journal of Neuropsychiatry, 2, S1–S10.Google Scholar
Schildkraut, J. J. (1973) Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting response to treatment: preliminary findings. American Journal of Psychiatry, 130, 695–8.Google Scholar
Spitzer, R. L., Endicott, J., Robins, E. et al (1975) Preliminary report of the reliability of research diagnostic criteria applied to psychiatric case records. In Prediction in Psychopharmacology (eds Gershon, S. and Beer, R.). New York: Raven Press.Google Scholar
Steen, R. B. (1933) Prognosis in manic-depressive psychoses. Psychiatric Quarterly, 7, 419–29.CrossRefGoogle Scholar
Strecker, E. A., Appel, K. E., Eyman, E. V. et al (1931) The prognosis in manic-depressive psychosis. Association for Research in Nervous and Mental Disease, 11, 471–537.Google Scholar
van Praag, H. M. (1974) Towards a biochemical typology of depression? Pharmakopsychiatry, 7, 281–92.Google Scholar
West, E. D. & Dally, P. J. (1959) Effects of iproniazid in depressive syndromes. British Medical Journal, i, 1491–4.Google Scholar
Wilson, I. C., Rabon, A. M. & Buffaloe, W. J. (1967) Imipramine therapy in depressive syndromes: prediction of therapeutic outcome. Psychosomatics, 8, 203–7.CrossRefGoogle Scholar
Winokur, G. (1973) The types of affective disease. Journal of Nervous and Mental Disease, 156, 82–96.Google Scholar
Winokur, G., Morrison, J., Clancy, J. et al (1972) The Iowa 500. Archives of General Psychiatry, 27, 462–4.Google Scholar
Wittenborn, J. R., Kiremitci, N. & Weber, E. (1962) The choice of alternative antidepressants. Journal of Nervous and Mental Disease, 156, 97–108.Google Scholar
Zung, W. W. K. (1974) From art to science. Archives of General Psychiatry, 29, 328–37.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.